Schedule 13G ownership disclosure
Sarepta Therapeutics Inc
Security class unavailable · CUSIP: 803607100
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,075,887
- Percent of class
- 3.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-17-000044
- Form type
- SC 13G
- Filer
- SABBY MANAGEMENT, LLC
- CIK
- CIK 1535610
- Filed
- Jan 10, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership